Amy J. Mathers

Narayanan, N., Mathers, A. J., Wenzler, E., Moore, N. M., Giske, C. G., Mendes, R. E., & Edelstein, P. H. (2024). Amoxicillin-Clavulanate Breakpoints Against Haemophilus influenzae: Rationale for Revision by the Clinical and Laboratory Standards Institute. CLINICAL INFECTIOUS DISEASES. doi:10.1093/cid/ciae246

Narayanan, N., Mathers, A. J., Wenzler, E., Moore, N. M., Giske, C. G., Mendes, R. E., & Edelstein, P. H. (2024). Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute. CLINICAL INFECTIOUS DISEASES. doi:10.1093/cid/ciae201

Bryson, A. L., Bhalodi, A., Liesman, R. M., & Mathers, A. J. (2024). Cefazolin as a predictor of urinary cephalosporin activity in indicated Enterobacterales. JOURNAL OF CLINICAL MICROBIOLOGY, 62(4). doi:10.1128/jcm.00788-21

Freiberg, J. A., Tao, L., Manuel, C., Mike, L. A., Nelson, G. E., Harris, B. D., . . . Humphries, R. M. (2024). A multi-species outbreak of VIM-producing carbapenem-resistant bacteria in a burn unit and subsequent investigation of rapid development of cefiderocol resistance. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 68(4). doi:10.1128/aac.01507-23

Humphries, R. M., Abbott, A. N., Alby, K., Bard, J. D., Harrington, A. T., Mathers, A. J., & Simner, P. J. (2023). Reply to "Letter responding to performance of updated Enterobacterales piperacillin-tazobactam breakpoints on the MicroScan antimicrobial susceptibility testing system". JOURNAL OF CLINICAL MICROBIOLOGY. doi:10.1128/jcm.00691-23

Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2023). Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. CLINICAL INFECTIOUS DISEASES. doi:10.1093/cid/ciad428

Hsu, A. J., Simner, P. J., Bergman, Y., Mathers, A. J., & Tamma, P. D. (2023). Successful Treatment of Persistent Stenotrophomonas maltophilia Bacteremia With Cefiderocol in an Infant. OPEN FORUM INFECTIOUS DISEASES, 10(4). doi:10.1093/ofid/ofad174

Tamma, P. D., Mathers, A. J., & Wenzler, E. (2023). Reply to Davis et al. CLINICAL INFECTIOUS DISEASES, 77(1), 163-165. doi:10.1093/cid/ciad170

Simner, P. J., Palavecino, E. L., Satlin, M. J., Mathers, A. J., Weinstein, M. P., Lewis II, J. S., & Humphries, R. (2023). Potential of Inaccurate Cefiderocol Susceptibility Results: a CLSI AST Subcommittee Advisory. JOURNAL OF CLINICAL MICROBIOLOGY, 61(4). doi:10.1128/jcm.01600-22

Bixby, M. L., Salay, J. M., Krueger, A. R., Mathers, A. J., & Hirsch, E. B. (2023). Fosfomycin Disk Diffusion Testing among Klebsiella pneumoniae Results in Frequent Inner Colonies and Categorical Disagreement Based on Conflicting Breakpoint Organization Recommendations. MICROBIOLOGY SPECTRUM, 11(2). doi:10.1128/spectrum.03363-22

Manuel, C., Maynard, R., Abbott, A., Adams, K., Alby, K., Sweeney, A., . . . Humphries, R. M. M. (2023). Evaluation of Piperacillin-Tazobactam Testing against Enterobacterales by the Phoenix, MicroScan, and Vitek2 Tests Using Updated Clinical and Laboratory Standards Institute Breakpoints. JOURNAL OF CLINICAL MICROBIOLOGY, 61(2). doi:10.1128/jcm.01617-22

Tamma, P. D., Harris, P. N. A., Mathers, A. J., Wenzler, E., & Humphries, R. M. (2023). Deconstructing the 2023 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Pseudomonas aeruginosa. CLINICAL INFECTIOUS DISEASES, 76(10), 1868-1870. doi:10.1093/cid/ciad012

Hudson, M. J., Park, S. C., Mathers, A., Parikh, H., Glowicz, J., Dar, D., . . . Perkins, K. M. (2022). Outbreak of Burkholderia stabilis Infections Associated with Contaminated Nonsterile, Multiuse Ultrasound Gel-10 States, May-September 2021. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 71(48), 1517-1521. Retrieved from https://www.webofscience.com/

Robinson, E. D., Keng, M. K., Thomas, T. D., Cox, H. L., Park, S. C., & Mathers, A. J. (2022). Reducing Repeat Blood Cultures in Febrile Neutropenia: A Single-Center Experience. OPEN FORUM INFECTIOUS DISEASES, 9(11). doi:10.1093/ofid/ofac521

Tamma, P. D., Harris, P. N. A., Mathers, A. J., Wenzler, E., & Humphries, R. M. (2023). Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Enterobacterales. CLINICAL INFECTIOUS DISEASES, 77(11), 1585-1590. doi:10.1093/cid/ciac688

Sasson, J., Donlan, A. N., Ma, J. Z., Haughey, H. M., Coleman, R., Nayak, U., . . . Petri, W. A. J. (2022). Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019: A Phase 2a Trial. OPEN FORUM INFECTIOUS DISEASES, 9(8). doi:10.1093/ofid/ofac343

Kotay, S. M., Tanabe, K. O., Colosi, L. M., Poulter, M. D., Barry, K. E., Holstege, C. P., . . . Porter, M. D. (2022). Building-Level Wastewater Surveillance for SARS-CoV-2 in Occupied University Dormitories as an Outbreak Forecasting Tool: One Year Case Study. ACS ES&T WATER, 2(11), 2094-2104. doi:10.1021/acsestwater.2c00057

Sasson, J., Donlan, A. N., Ma, J. Z., Haughey, H. M., Coleman, R., Nayak, U., . . . Petri, W. A. (2022). Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa Trial.. medRxiv. doi:10.1101/2022.03.30.22273194

Mojica, M. F., Humphries, R., Lipuma, J. J., Mathers, A. J., Rao, G. G., Shelburne, S. A., . . . Bonomo, R. A. (2022). Clinical challenges treating Stenotrophomonas maltophilia infections: an update. JAC-ANTIMICROBIAL RESISTANCE, 4(3). doi:10.1093/jacamr/dlac040

Humphries, R., Tamma, P. D., & Mathers, A. J. (2022). Disk Correlates for Revised Clinical and Laboratory Standards Institute Enterobacterales Piperacillin-Tazobactam MIC Breakpoints. JOURNAL OF CLINICAL MICROBIOLOGY, 60(5). doi:10.1128/jcm.00243-22

Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2022). Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa). CLINICAL INFECTIOUS DISEASES, 75(2), 187-212. doi:10.1093/cid/ciac268

Loudermilk, E. M., Kotay, S. M., Barry, K. E., Parikh, H. I., Colosi, L. M., & Mathers, A. J. (2022). Tracking Klebsiella pneumoniae carbapenemase gene as an indicator of antimicrobial resistance dissemination from a hospital to surface water via a municipal wastewater treatment plant. WATER RESEARCH, 213. doi:10.1016/j.watres.2022.118151

Sturek, J. M., Thomas, T. A., Gorham, J. D., Sheppard, C. A., Raymond, A. H., Petros De Guex, K., . . . Heysell, S. K. (2022). Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile.. Microbiology spectrum, 10(1), e0256021. doi:10.1128/spectrum.02560-21

Marino, A. C., Robinson, E. D., Durden, J. A., Cox, H. L., Mathers, A. J., & Shaffrey, M. E. (2022). The effects of avoiding extended antimicrobial drain prophylaxis on Clostridioides difficile and postprocedural infection rates: a 5-year retrospective. JOURNAL OF NEUROSURGERY, 137(4), 1153-1159. doi:10.3171/2021.11.JNS211459

Kamruzzaman, M., Mathers, A. J., & Iredell, J. R. (2022). A Novel Plasmid Entry Exclusion System in pKPC_UVA01, a Promiscuous Conjugative Plasmid Carrying the bla_KPC Carbapenemase Gene. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 66(3). doi:10.1128/aac.02322-21

Pierce, V. M., & Mathers, A. J. (2022). Setting Antimicrobial Susceptibility Testing Breakpoints: A Primer for Pediatric Infectious Diseases Specialists on the Clinical and Laboratory Standards Institute Approach. JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 11(2), 73-80. doi:10.1093/jpids/piab106

Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2022). Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections. CLINICAL INFECTIOUS DISEASES, 74(12), 2089-2114. doi:10.1093/cid/ciab1013

Donlan, A. N., Sutherland, T. E., Marie, C., Preissner, S., Bradley, B. T., Carpenter, R. M., . . . Petri, W. A. J. (2021). IL-13 is a driver of COVID-19 severity. JCI INSIGHT, 6(15). doi:10.1172/jci.insight.150107

Dunphy, L. J., Kolling, G. L., Jenior, M. L., Carroll, J., Attai, A. E., Farnoud, F., . . . Papin, J. A. (2021). Multidimensional Clinical Surveillance of Pseudomonas aeruginosa Reveals Complex Relationships between Isolate Source, Morphology, and Antimicrobial Resistance. MSPHERE, 6(4). doi:10.1128/mSphere.00393-21

Colosi, L. M., Barry, K. E., Kotay, S. M., Porter, M. D., Poulter, M. D., Ratliff, C., . . . Mathers, A. J. (2021). Development of Wastewater Pooled Surveillance of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) from Congregate Living Settings. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 87(13). doi:10.1128/AEM.00433-21

Mathers, A. J., & Lewis, J. S. I. I. (2021). CON: Testing for ESBL production is unnecessary for ceftriaxone-resistant Enterobacterales. JAC-ANTIMICROBIAL RESISTANCE, 3(2). doi:10.1093/jacamr/dlab020

Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2021). Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa). CLINICAL INFECTIOUS DISEASES, 72(7), 1109-1116. doi:10.1093/cid/ciab295

Donlan, A. N., Sutherland, T. E., Marie, C., Preissner, S., Bradley, B. T., Carpenter, R. M., . . . Petri, W. A. (2021). IL-13 is a driver of COVID-19 severity.. medRxiv. doi:10.1101/2020.06.18.20134353

Tamma, P. D., & Mathers, A. J. (2021). Navigating treatment approaches for presumed ESBL-producing infections. JAC-ANTIMICROBIAL RESISTANCE, 3(1). doi:10.1093/jacamr/dlaa111

Sturek, J. M., Thomas, T. A., Gorham, J. D., Sheppard, C. A., Raymond, A. E., De Guex, K. P., . . . Heysell, S. K. (2022). Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile. MICROBIOLOGY SPECTRUM, 10(1). Retrieved from https://www.webofscience.com/

Park, S. C., Gillis-Crouch, G. R., Cox, H. L., Donohue, L., Morse, R., Vegesana, K., & Mathers, A. J. (2021). Consecutive Antibiotic Shortages Highlight Discrepancies between Microbiology and Prescribing Practices for Intra-abdominal Infections. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 65(5). doi:10.1128/AAC.01980-20

Robinson, E. D., Stilwell, A. M., Attai, A. E., Donohue, L. E., Shah, M. D., Hill, B. K., . . . Mathers, A. J. (2021). Implementation of a Rapid Phenotypic Susceptibility Platform for Gram-Negative Bloodstream Infections With Paired Antimicrobial Stewardship Intervention: Is the Juice Worth the Squeeze?. CLINICAL INFECTIOUS DISEASES, 73(5), 783-792. doi:10.1093/cid/ciab126

Burgos-Garay, M., Ganim, C., de Man, T. J. B., Davy, T., Mathers, A. J., Kotay, S., . . . Donlan, R. M. (2021). Colonization of carbapenem-resistant Klebsiella pneumoniae in a sink-drain model biofilm system. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 42(6), 722-730. doi:10.1017/ice.2020.1287

Park, S. C., Parikh, H., Vegesana, K., Stoesser, N., Barry, K. E., Kotay, S. M., . . . Mathers, A. J. (2020). Risk Factors Associated with Carbapenemase-Producing Enterobacterales (CPE) Positivity in the Hospital Wastewater Environment. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 86(24). doi:10.1128/AEM.01715-20

Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2021). Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa). CLINICAL INFECTIOUS DISEASES, 72(7), E169-E183. doi:10.1093/cid/ciaa1478

Mathers, A. J. (2021). The Practical Challenges of Making Clinical Use of the Quantitative Value for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load Across Several Dynamics. CLINICAL INFECTIOUS DISEASES, 73(11), E4206-E4207. doi:10.1093/cid/ciaa958

Constantinides, B., Chau, K. K., Quan, T. P., Rodger, G., Andersson, M. I., Jeffery, K., . . . Stoesser, N. (2020). Genomic surveillance of Escherichia coli and Klebsiella spp. in hospital sink drains and patients. MICROBIAL GENOMICS, 6(7). doi:10.1099/mgen.0.000391

Davies, T. J., Stoesser, N., Sheppard, A. E., Abuoun, M., Fowler, P., Swann, J., . . . Walker, A. S. (2020). Reconciling the Potentially Irreconcilable? Genotypic and Phenotypic Amoxicillin-Clavulanate Resistance in Escherichia coli. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 64(6). doi:10.1128/AAC.02026-19

Stoesser, N., Phan, H. T. T., Seale, A. C., Aiken, Z., Thomas, S., Smith, M., . . . Walker, A. S. (2020). Genomic Epidemiology of Complex, Multispecies, Plasmid-Borne bla_KPC Carbapenemase in Enterobacterales in the United Kingdom from 2009 to 2014. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 64(5). doi:10.1128/AAC.02244-19

Kotay, S. M., Parikh, H. I., Barry, K., Gweon, H. S., Guilford, W., Carroll, J., & Mathers, A. J. (2020). Nutrients influence the dynamics of Klebsiella pneumoniae carbapenemase producing enterobacterales in transplanted hospital sinks. WATER RESEARCH, 176. doi:10.1016/j.watres.2020.115707

Robinson, E. D., Volles, D. F., Kramme, K., Mathers, A. J., & Sawyer, R. G. (2020). Collaborative Antimicrobial Stewardship for Surgeons. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 34(1), 97-+. doi:10.1016/j.idc.2019.11.002

Gordon, A. K., Phan, H. T. T., Lipworth, S. I., Cheong, E., Gottlieb, T., George, S., . . . Stoesser, N. (2020). Genomic dynamics of species and mobile genetic elements in a prolonged bla_IMP-4-associated carbapenemase outbreak in an Australian hospital. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 75(4), 873-882. doi:10.1093/jac/dkz526

Mathers, A. J., Vegesana, K., German-Mesner, I., Ainsworth, J., Pannone, A., Crooke, D. W., . . . Eyre, D. W. (2020). Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species. JOURNAL OF HOSPITAL INFECTION, 104(4), 456-468. doi:10.1016/j.jhin.2020.01.005

Elliott, Z. S., Barry, K. E., Cox, H. L., Stoesser, N., Carroll, J., Vegesana, K., . . . Mathers, A. J. (2019). The Role of fosA in Challenges with Fosfomycin Susceptibility Testing of Multispecies Klebsiella pneumoniae Carbapenemase-Producing Clinical Isolates. JOURNAL OF CLINICAL MICROBIOLOGY, 57(10). doi:10.1128/JCM.00634-19

Operario, D. J., Pholwat, S., Koeppel, A. F., Prorock, A., Bao, Y., Sol-Church, K., . . . Houpt, E. R. (2019). Mycobacterium avium Complex Diversity within Lung Disease, as Revealed by Whole-Genome Sequencing. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 200(3), 393-396. doi:10.1164/rccm.201903-0669LE

Park, S. C., Wailan, A. M., Barry, K. E., Vegesana, K., Carroll, J., Mathers, A. J., . . . Munita, J. M. (2019). Managing All the Genotypic Knowledge: Approach to a Septic Patient Colonized by Different Enterobacteriales with Unique Carbapenemases. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 63(8). doi:10.1128/AAC.00029-19

Mathers, A. J., Crook, D., Vaughan, A., Barry, K. E., Vegesana, K., Stoesser, N., . . . Sheppard, A. E. (2019). Klebsiella quasipneumoniae Provides a Window into Carbapenemase Gene Transfer, Plasmid Rearrangements, and Patient Interactions with the Hospital Environment. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 63(6). doi:10.1128/AAC.02513-18

Reeme, A. E., Bowler, S. L., Buchan, B. W., Graham, M. B., Behrens, E., Singh, S., . . . Munoz-Price, L. S. (2019). Use of a cohorting-unit and systematic surveillance cultures to control a Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae outbreak. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 40(7), 767-773. doi:10.1017/ice.2019.99

Clark, S. D., Sidlak, M., Mathers, A. J., Poulter, M., & Platts-Mills, J. A. (2019). Clinical Yield of a Molecular Diagnostic Panel for Enteric Pathogens in Adult Outpatients With Diarrhea and Validation of Guidelines-Based Criteria for Testing. OPEN FORUM INFECTIOUS DISEASES, 6(4). doi:10.1093/ofid/ofz162

Barry, K. E., Wailan, A. M., Sheppard, A. E., Crook, D., Vegesana, K., Stoesser, N., . . . Mathers, A. J. (2019). Don't overlook the little guy: An evaluation of the frequency of small plasmids co-conjugating with larger carbapenemase gene containing plasmids. PLASMID, 103, 1-8. doi:10.1016/j.plasmid.2019.03.005

Kotay, S. M., Donlan, R. M., Ganim, C., Barry, K., Christensen, B. E., & Mathers, A. J. (2019). Droplet- Rather than Aerosol-Mediated Dispersion Is the Primary Mechanism of Bacterial Transmission from Contaminated Hand-Washing Sink Traps. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 85(2). doi:10.1128/AEM.01997-18

Athans, V., Neuner, E. A., Hassouna, H., Richter, S. S., Keller, G., Castanheira, M., . . . Mathers, A. J. (2019). Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-Resistant Klebsiella pneumoniae Bacteremia and Abscess in a Liver Transplant Recipient. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 63(1). doi:10.1128/AAC.01551-18

Aranega-Bou, P., George, R. P., Verlander, N. Q., Paton, S., Bennett, A., Moore, G., & TRACE Investigators' Group. (2019). Carbapenem-resistant Enterobacteriaceae dispersal from sinks is linked to drain position and drainage rates in a laboratory model system.. The Journal of hospital infection, 102(1), 63-69. doi:10.1016/j.jhin.2018.12.007

Decraene, V., Phan, H. T. T., George, R., Wyllie, D. H., Akinremi, O., Aiken, Z., . . . Cawthorne, J. (2018). A Large, Refractory Nosocomial Outbreak of Klebsiella pneumoniae Carbapenemase-Producing Escherichia coli Demonstrates Carbapenemase Gene Outbreaks Involving Sink Sites Require Novel Approaches to Infection Control. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 62(12). doi:10.1128/AAC.01689-18

Sheppard, A. E., Stoesser, N., German-Mesner, I., Vegesana, K., Walker, A. S., Crook, D. W., & Mathers, A. J. (2018). TETyper: a bioinformatic pipeline for classifying variation and genetic contexts of transposable elements from short-read whole-genome sequencing data. MICROBIAL GENOMICS, 4(12). doi:10.1099/mgen.0.000232

Wunderink, R. G., Giamarellos-Bourboulis, E. J., Rahav, G., Mathers, A. J., Bassetti, M., Vazquez, J., . . . Kaye, K. S. (2018). Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial. INFECTIOUS DISEASES AND THERAPY, 7(4), 439-455. doi:10.1007/s40121-018-0214-1

Gray, M. E., Cox, H. L., Donohue, L. E., Poulter, M. D., Eby, J. C., & Mathers, A. J. (2018). The effect of rapid diagnostic testing with Infectious Diseases fellow consultative intervention on the management of enterococcal bloodstream infection. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 92(4), 319-324. doi:10.1016/j.diagmicrobio.2018.07.004

Humphries, R. M., Hindler, J., Ferraro, M. J., & Mathers, A. (2018). Twenty-first Century Cures Act and Antimicrobial Susceptibility Testing: Clinical Implications in the Era of Multidrug Resistance. CLINICAL INFECTIOUS DISEASES, 67(7), 1132-1138. doi:10.1093/cid/ciy432

Grabowski, M., Lobo, J. M., Gunnell, B., Enfield, K., Carpenter, R., Barnes, L., & Mathers, A. J. (2018). Characterizations of handwashing sink activities in a single hospital medical intensive care unit. JOURNAL OF HOSPITAL INFECTION, 100(3), E115-E122. doi:10.1016/j.jhin.2018.04.025

Madden, G. R., Mesner, I. G., Cox, H. L., Mathers, A. J., Lyman, J. A., Sifri, C. D., & Enfield, K. B. (2018). Reduced Clostridium difficile Tests and Laboratory-Identified Events With a Computerized Clinical Decision Support Tool and Financial Incentive. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 39(6), 737-740. doi:10.1017/ice.2018.53

George, S., Pankhurst, L., Hubbard, A., Votintseva, A., Stoesser, N., Sheppard, A. E., . . . Phan, H. T. T. (2018). Resolving plasmid structures in Enterobacteriaceae using the MinION nanopore sequencer: assessment of MinION and MinION/Illumina hybrid data assembly approaches (vol 3, 2017). MICROBIAL GENOMICS, 4(3). doi:10.1099/mgen.0.000130

Fleece, M. E., Pholwat, S., Mathers, A. J., & Houpt, E. R. (2018). Molecular diagnosis of antimicrobial resistance in Escherichia coli. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 18(3), 207-217. doi:10.1080/14737159.2018.1439381

Mathers, A. J., Vegesana, K., Mesner, I. G., Barry, K. E., Pannone, A., Baumann, J., . . . Sifri, C. D. (2018). Intensive Care Unit Wastewater Interventions to Prevent Transmission of Multispecies Klebsiella pneumoniae Carbapenemase-Producing Organisms. CLINICAL INFECTIOUS DISEASES, 67(2), 171-178. doi:10.1093/cid/ciy052

Mathers, A., Crook, D., Vaughan, A., Barry, K., Vegesana, K., Stoesser, N., . . . Sheppard, A. (2018). Klebsiella quasipneumonaiae provides a window into carbapenemase gene transfer, plasmid rearrangements and nosocomial acquisition from the hospital environment. doi:10.1101/486753

Eby, J. C., Mathers, A. J., Cox, H. L., Richey, M. M., Platts-Mills, J. A., & Novicoff, W. M. (2018). A Request for Standardization of Publishing of Blood Culture Processing Interventions Reply. CLINICAL INFECTIOUS DISEASES, 66(9), 1485. doi:10.1093/cid/cix1017

Grabowski, M. E., Kang, H., Wells, K. M., Sifri, C. D., Mathers, A. J., & Lobo, J. M. (2017). Provider Role in Transmission of Carbapenem-Resistant Enterobacteriaceae. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 38(11), 1329-1334. doi:10.1017/ice.2017.216

Eby, J. C., Richey, M. M., Platts-Mills, J. A., Mathers, A. J., Novicoff, W. M., & Cox, H. L. (2018). A Healthcare Improvement Intervention Combining Nucleic Acid Microarray Testing With Direct Physician Response for Management of Staphylococcus aureus Bacteremia. CLINICAL INFECTIOUS DISEASES, 66(1), 64-71. doi:10.1093/cid/cix727

Stoesser, N., Sheppard, A. E., Peirano, G., Anson, L. W., Pankhurst, L., Sebra, R., . . . Pitout, J. D. (2017). Genomic epidemiology of global Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia coli. SCIENTIFIC REPORTS, 7. doi:10.1038/s41598-017-06256-2

George, S., Pankhurst, L., Hubbard, A., Votintseva, A., Stoesser, N., Sheppard, A. E., . . . Phan, H. T. T. (2017). Resolving plasmid structures in Enterobacteriaceae using the MinION nanopore sequencer: assessment of MinION and MinION/Illumina hybrid data assembly approaches. MICROBIAL GENOMICS, 3(8). doi:10.1099/mgen.0.000118

Cheruvanky, A., Stoesser, N., Sheppard, A. E., Crook, D. W., Hoffman, P. S., Weddle, E., . . . Mathers, A. J. (2017). Enhanced Klebsiella pneumoniae Carbapenemase Expression from a Novel Tn4401 Deletion. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61(6). doi:10.1128/AAC.00025-17

Kotay, S., Chai, W., Guilford, W., Barry, K., & Mathers, A. J. (2017). Spread from the Sink to the Patient: In Situ Study Using Green Fluorescent Protein (GFP)-Expressing Escherichia coli To Model Bacterial Dispersion from Hand-Washing Sink-Trap Reservoirs. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 83(8). doi:10.1128/AEM.03327-16

Mathers, A. J., Stoesser, N., Chai, W., Carroll, J., Barry, K., Cherunvanky, A., . . . Sheppard, A. E. (2017). Chromosomal Integration of the Klebsiella pneumoniae Carbapenemase Gene, bla_KPC, in Klebsiella Species Is Elusive but Not Rare. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61(3). doi:10.1128/AAC.01823-16

Gordon, A. E. K., Mathers, A. J., Cheong, E. Y. L., Gottlieb, T., Kotay, S., Walker, A. S., . . . Stoesser, N. (2017). The Hospital Water Environment as a Reservoir for Carbapenem-Resistant Organisms Causing Hospital-Acquired Infections-A Systematic Review of the Literature. CLINICAL INFECTIOUS DISEASES, 64(10), 1435-1444. doi:10.1093/cid/cix132

Wunderink, R., Giamarellos-Bourboulis, E., Rahav, G., Mathers, A., Bassetti, M., Solomkin, J., . . . Kaye, K. S. (2017). Meropenem-Vaborbactam vs. Best AvailableTherapy for Carbapenem-ResistantEnterobacteriaceae Infections in TANGO II: PrimaryOutcomes by Site of Infection. Open Forum Infectious Diseases, 4(suppl_1), S536-S537. doi:10.1093/ofid/ofx163.1397

Mathers, A., Hope, W., Kaye, K. S., Loutit, J. S., Alexander, E., Dudley, M. N., & Vazquez, J. (2017). Meropenem-Vaborbactam: Outcomes in Subjects with Renal Impairment in Phase 3 Studies TANGO I and II. Open Forum Infectious Diseases, 4(suppl_1), S542. doi:10.1093/ofid/ofx163.1409

Kaye, K. S., Vazquez, J., Mathers, A., Daikos, G., Alexander, E., Loutit, J. S., . . . Cornely, O. (2017). Clinical Outcomes of Serious Infections due to Carbapenem-Resistant Enterobacteriaceae (CRE) in TANGO II, a Phase 3, Randomized, Multi-National, Open-Label Trial of Meropenem-Vaborbactam (M-V) Vs. Best Available Therapy (BAT). Open Forum Infectious Diseases, 4(suppl_1), S534-S535. doi:10.1093/ofid/ofx163.1392

Julia, L., Vilankar, K., Kang, H., Brown, D. E., Mathers, A., & Barnes, L. E. (2017). Environmental Reservoirs of Nosocomial Infection: Imputation Methods for Linking Clinical and Environmental Microbiological Data to Understand Infection Transmission.. AMIA ... Annual Symposium proceedings. AMIA Symposium, 2017, 1120-1129.

Gray, M., Hall, H. C., Poulter, M., Eby, J., & Mathers, A. (2016). Impact of Infectious Disease Fellow Consultative Intervention Combined With a Rapid Gram-Positive Blood Culture Microarray on Outcomes for Patients With Enterococcal Bloodstream Infection. Open Forum Infectious Diseases, 3(suppl_1). doi:10.1093/ofid/ofw172.718

Kolbe, L., Cox, H., Poulter, M., Eby, J., & Mathers, A. (2016). Vancomycin Exposure in Patients With Coagulase-Negative Staphylococcus Identified From Blood Cultures Before and After Introduction of a Rapid Microarray Assay. Open Forum Infectious Diseases, 3(suppl_1). doi:10.1093/ofid/ofw172.35

Hardiman, C. A., Weingarten, R. A., Conlan, S., Khil, P., Dekker, J. P., Mathers, A. J., . . . Frank, K. M. (2016). Horizontal Transfer of Carbapenemase-Encoding Plasmids and Comparison with Hospital Epidemiology Data. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 60(8), 4910-4919. doi:10.1128/AAC.00014-16

Mathers, A. (2016). Mobilization of Carbapenemase-Mediated Resistance in Enterobacteriaceae. EMERGING INFECTIONS 10, 201-212. doi:10.1128/microbiolspec.EI10-0010-2015

Sheppard, A. E., Stoesser, N., Wilson, D. J., Sebra, R., Kasarskis, A., Anson, L. W., . . . Mathers, A. J. (2016). Nested Russian Doll-Like Genetic Mobility Drives Rapid Dissemination of the Carbapenem Resistance Gene bla_KPC. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 60(6), 3767-3778. doi:10.1128/AAC.00464-16

Lewis, J. D., Enfield, K. B., Cox, H. L., Mathers, A. J., & Sifri, C. D. (2016). A single-center experience with infections due to daptomycin-nonsusceptible Enterococcus faecium in liver transplant recipients. TRANSPLANT INFECTIOUS DISEASE, 18(3), 341-353. doi:10.1111/tid.12523

Sheppard, A. E., Stoesser, N., Sebra, R., Kasarskis, A., Deikus, G., Anson, L., . . . Mathers, A. J. (2016). Complete Genome Sequence of KPC-Producing Klebsiella pneumoniae Strain CAV1193. GENOME ANNOUNCEMENTS, 4(1). doi:10.1128/genomeA.01649-15

Stoesser, N., Mathers, A. J., Moore, C. E., Day, N. P. J., & Crook, D. W. (2016). Colistin resistance gene mcr-1 and pHNSHP45 plasmid in human isolates of Escherichia coli and Klebsiella pneumoniae. LANCET INFECTIOUS DISEASES, 16(3), 285-286. doi:10.1016/S1473-3099(16)00010-4

Schutte, K. M., Fisher, D. J., Burdick, M. D., Mehrad, B., Mathers, A. J., Mann, B. J., . . . Hughes, M. A. (2016). Escherichia coli Pyruvate Dehydrogenase Complex Is an Important Component of CXCL10-Mediated Antimicrobial Activity. INFECTION AND IMMUNITY, 84(1), 320-328. doi:10.1128/IAI.00552-15

Mathers, A. J., Peirano, G., & Pitout, J. D. D. (2015). The Role of Epidemic Resistance Plasmids and International High-Risk Clones in the Spread of Multidrug-Resistant Enterobacteriaceae. CLINICAL MICROBIOLOGY REVIEWS, 28(3), 565-591. doi:10.1128/CMR.00116-14

Mathers, A. J. (2015). Antibiotics in laboratory medicine, 6th edition.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 60(9), 1446-1447. doi:10.1093/cid/civ078

Day, S. R., Smith, D., Harris, K., Cox, H. L., & Mathers, A. J. (2015). An Infectious Diseases Physician-Led Antimicrobial Stewardship Program at a Small Community Hospital Associated With Improved Susceptibility Patterns and Cost-Savings After the First Year. OPEN FORUM INFECTIOUS DISEASES, 2(2). doi:10.1093/ofid/ofv064

Lewis, J. D., Enfield, K. B., Mathers, A. J., Giannetta, E. T., & Sifri, C. D. (2015). The Limits of Serial Surveillance Cultures in Predicting Clearance of Colonization with Carbapenemase-Producing Enterobacteriaceae. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 36(7), 835-837. doi:10.1017/ice.2015.57

Mathers, A. J., Stoesser, N., Sheppard, A. E., Pankhurst, L., Giess, A., Yeh, A. J., . . . Sifri, C. D. (2015). Klebsiella pneumoniae Carbapenemase (KPC)-Producing K-pneumoniae at a Single Institution: Insights into Endemicity from Whole-Genome Sequencing. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 59(3), 1661-1668. doi:10.1128/AAC.04292-14

Lewis, J., Enfield, K., Mathers, A., Giannetta, E., & Sifri, C. D. (2014). 364Utility of Carbapenem-Resistant Enterobacteriaceae Surveillance Cultures in Predicting Clearance of Colonization. Open forum infectious diseases, 1(Suppl 1), S143.

Mathers, A. J., Peirano, G., & Pitout, J. D. D. (2015). Escherichia coli ST131: The Quintessential Example of an International Multiresistant High-Risk Clone. ADVANCES IN APPLIED MICROBIOLOGY, VOL 90, 90, 109-154. doi:10.1016/bs.aambs.2014.09.002

Enfield, K. B., Huq, N. N., Gosseling, M. F., Low, D. J., Hazen, K. C., Toney, D. M., . . . Sifri, C. D. (2014). Control of Simultaneous Outbreaks of Carbapenemase-Producing Enterobacteriaceae and Extensively Drug-Resistant Acinetobacter baumannii Infection in an Intensive Care Unit Using Interventions Promoted in the Centers for Disease Control and Prevention 2012 Carbapenemase-Resistant Enterobacteriaceae Toolkit. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 35(7), 810-817. doi:10.1086/676857

Mathers, A. J., Poulter, M., Dirks, D., Carroll, J., Sifri, C. D., & Hazen, K. C. (2014). Clinical Microbiology Costs for Methods of Active Surveillance for Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 35(4), 350-355. doi:10.1086/675603

Mathers, A. J., & Guerrant, R. L. (2014). Dissecting the evolutionary stealth of our flora against antibiotics. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 108(3), 121-122. doi:10.1093/trstmh/tru002

Adler, A., Khabra, E., Chmelnitsky, I., Giakkoupi, P., Vatopoulos, A., Mathers, A. J., . . . Carmeli, Y. (2014). Development and validation of a multiplex PCR assay for identification of the epidemic ST-258/512 KPC-producing Klebsiella pneumoniae clone. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 78(1), 12-15. doi:10.1016/j.diagmicrobio.2013.10.003

Lewis, J. D., Bishop, M., Heon, B., Mathers, A. J., Enfield, K. B., & Sifri, C. D. (2013). Admission Surveillance for Carbapenamase-Producing Enterobacteriaceae at a Long-Term Acute Care Hospital. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 34(8), 832-834. doi:10.1086/671263

Mathers, A. J., Carroll, J., Sifri, C. D., & Hazen, K. C. (2013). Modified Hodge Test versus Indirect Carbapenemase Test: Prospective Evaluation of a Phenotypic Assay for Detection of Klebsiella pneumoniae Carbapenemase (KPC) in Enterobacteriaceae. JOURNAL OF CLINICAL MICROBIOLOGY, 51(4), 1291-1293. doi:10.1128/JCM.03240-12

Mathers, A. J., Hazen, K. C., Carroll, J., Yeh, A. J., Cox, H. L., Bonomo, R. A., & Sifri, C. D. (2013). First Clinical Cases of OXA-48-Producing Carbapenem-Resistant Klebsiella pneumoniae in the United States: the "Menace" Arrives in the New World (vol 51, pg 680, 2013). JOURNAL OF CLINICAL MICROBIOLOGY, 51(4), 1352. doi:10.1128/JCM.00221-13

Mathers, A. J., Hazen, K. C., Carroll, J., Yeh, A. J., Cox, H. L., Bonomo, R. A., & Sifri, C. D. (2013). First Clinical Cases of OXA-48-Producing Carbapenem-Resistant Klebsiella pneumoniae in the United States: the "Menace" Arrives in the New World. JOURNAL OF CLINICAL MICROBIOLOGY, 51(2), 680-683. doi:10.1128/JCM.02580-12

MacQueen, D. D., Lubelczyk, C., Elias, S. P., Cahill, B. K., Mathers, A. J., Lacombe, E. H., . . . Smith, R. P. J. (2012). Genotypic Diversity of an Emergent Population of Borrelia burgdorferi at a Coastal Maine Island Recently Colonized by Ixodes scapularis. VECTOR-BORNE AND ZOONOTIC DISEASES, 12(6), 456-461. doi:10.1089/vbz.2011.0811

Mathers, A., Smith, R. P., Cahill, B., Lubelczyk, C., Elias, S. P., Lacombe, E., . . . Rand, P. W. (2011). Strain diversity of Borrelia burgdorferi in ticks dispersed in North America by migratory birds. JOURNAL OF VECTOR ECOLOGY, 36(1), 24-29. doi:10.1111/j.1948-7134.2011.00137.x

Mathers, A. J., Cox, H. L., Kitchel, B., Bonatti, H., Brassinga, A. K. C., Carroll, J., . . . Sifri, C. D. (2011). Molecular Dissection of an Outbreak of Carbapenem-Resistant Enterobacteriaceae Reveals Intergenus KPC Carbapenemase Transmission through a Promiscuous Plasmid. MBIO, 2(6). doi:10.1128/mBio.00204-11